Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare Conference and BioCentury NewsMakers Conference
September 02 2004 - 8:15AM
PR Newswire (US)
Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare
Conference and BioCentury NewsMakers Conference SAN DIEGO, Sept. 2
/PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc.
(NASDAQ:AMLN) will be presenting at the Thomas Weisel Partners
Healthcare Tailwinds 2004 Conference on Wednesday, September 8,
2004 at 9:10 AM Eastern Time in Boston and at BioCentury's
NewsMakers in the Biotech Industry Conference on Thursday,
September 9, 2004 at 10:30 a.m. Eastern Time in New York. Mark G.
Foletta, Vice President, Finance and Chief Financial Officer of
Amylin Pharmaceuticals, will be providing a corporate overview at
Thomas Weisel. Ginger L. Graham, President & Chief Executive
Officer of Amylin Pharmaceuticals, will be presenting at
BioCentury. Both presentations will be webcast live, and recordings
will be made available following each presentation. The breakout
session at BioCentury will also be webcast live, and a recording
will be made available following the session. The webcasts and
recordings will be accessible through Amylin's corporate website,
located at http://www.amylin.com/. For access, please log on to
Amylin's site approximately fifteen minutes prior to the
presentations to register and download any necessary audio
software. Amylin Pharmaceuticals is committed to improving the
lives of people with diabetes and other metabolic diseases through
the discovery, development and commercialization of innovative,
cost-effective medicines. Further information on Amylin
Pharmaceuticals and its pipeline in metabolism is available at
http://www.amylin.com/. DATASOURCE: Amylin Pharmaceuticals CONTACT:
Mark G. Foletta, Vice President of Finance and Chief Financial
Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site:
http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024